Conference Reports for NATAP
Conference on Retroviruses
and Opportunistic Infections
Seattle, Washington
Feb 19-22 2023
Back
 
Tweet
SWITCH TO DOR/ISL (100/0.75MG) QD: WEEK 48 RESULTS FROM AN OPEN-LABEL PHASE 3 TRIAL
CROI 2023 Feb 20-23